Loading
Sections

Skip to content. | Skip to navigation

Center for Infectious Diseases
Administrative Offices Only - No Patients Access

CB# 7030
130 Mason Farm Road
2nd Floor Bioinformatics
Chapel Hill, NC 27599
T: (919) 966-2536
F: (919) 966-6714

 

UNC Infectious Diseases Clinic
For Patient Services and Care

101 Manning Drive
1st Floor Memorial Bldg.
Chapel Hill, NC  27514
T: (919) 966-7198
F: (919) 966-4587

 

Web master:
cfid@unc.edu

 
You are here: Home > Events > “HIV incidence assays – half-full or half-empty?”

“HIV incidence assays – half-full or half-empty?”

What
  • Lecture
When 2010-10-22
from 08:30 AM to 09:30 AM
Where 1131 Bioinformatics
Contact Name
Contact Phone (919) 966-2536
Presenter Timothy Mastro, MD, (FHI)
Lecture Series Infectious Diseases Friday Morning Conference
Sponsor CFID, IGHID, SOM, CFAR
Add event to calendar vCal
iCal

The Center for Infectious Diseases and the Institute for Global Health and Infectious Diseases co-sponsor a weekly conference series featuring distinguished clinicians and scientists from UNC, local universities and other national and international institutions. The topics are varied and appeal to not only infectious disease specialists, but also professionals in epidemiology, public health, microbiology, biostatistics and other global health-related disciplines.

Dr. Mastro is one of the leading experts on HIV/AIDS prevention. During his tenure at the CDC, Dr. Mastro oversaw HIV prevention research activities, including a landmark study on mother-to-child HIV transmission, trials of microbicides for women, and the first international HIV vaccine efficacy trial. He has also served as chief of the CDC HIV Vaccine Section and directed the CDC's participation in the President's Emergency Plan for AIDS Relief (PEPFAR). At FHI, Dr. Mastro serves as the vice president of health and development sciences. He supports the organization's commitment to continue to expand its global leadership role in public health and development, particularly in HIV/AIDS prevention and treatment research and programs.

Breakthrough of the Year!

The HIV Prevention Trials Network 052 study, led by center director Myron S. Cohen, M.D., has been named the 2011 Breakthrough of the Year by the journal Science.